Literature DB >> 25277817

Gene Therapy for Autoimmune Disease.

Shang-An Shu1, Jinjun Wang1, Mi-Hua Tao2, Patrick S C Leung3.   

Abstract

Advances in understanding the immunological and molecular basis of autoimmune diseases have made gene therapy a promising approach to treat the affected patients. Gene therapy for autoimmune diseases aims to regulate the levels of proinflammatory cytokines or molecules and the infiltration of lymphocytes to the effected sites through successful delivery and expression of therapeutic genes in appropriate cells. The ultimate goal of gene therapy is to restore and maintain the immune tolerance to the relevant autoantigens and improve clinical outcomes for patients. Here, we summarize the recent progress in identifying genes responsible for autoimmune diseases and present examples where gene therapy has been applied as treatments or prevention in autoimmune diseases both in animal models and the clinical trials. Discussion on the advantages and pitfalls of gene therapy strategies employed is provided. The intent of this review is to inspire further studies toward the development of new strategies for successful treatment of autoimmune diseases.

Entities:  

Keywords:  Animal model; Autoimmune disease; Clinical trial; Delivery vectors; Gene therapy

Mesh:

Substances:

Year:  2015        PMID: 25277817     DOI: 10.1007/s12016-014-8451-x

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  109 in total

1.  Differential effects of decoy chemokine (7ND) gene therapy on acute, biphasic and chronic autoimmune encephalomyelitis: implication for pathomechanisms of lesion formation.

Authors:  Il-Kwon Park; Keiko Hiraki; Kuniko Kohyama; Yoh Matsumoto
Journal:  J Neuroimmunol       Date:  2007-12-26       Impact factor: 3.478

Review 2.  Recent advances in DNA vaccines for autoimmune diseases.

Authors:  Celio L Silva; Vânia Ld Bonato; Rubens R dos Santos-Júnior; Carlos R Zárate-Bladés; Alexandrina Sartori
Journal:  Expert Rev Vaccines       Date:  2009-02       Impact factor: 5.217

Review 3.  Promotion and prevention of autoimmune disease by CD8+ T cells.

Authors:  David M Gravano; Katrina K Hoyer
Journal:  J Autoimmun       Date:  2013-07-17       Impact factor: 7.094

Review 4.  Adsorption of DNA onto anionic lipid surfaces.

Authors:  Alberto Martín-Molina; Germán Luque-Caballero; Jordi Faraudo; Manuel Quesada-Pérez; Julia Maldonado-Valderrama
Journal:  Adv Colloid Interface Sci       Date:  2013-11-27       Impact factor: 12.984

5.  Single-joint outcome measures: preliminary validation of patient-reported outcomes and physical examination.

Authors:  Alison E Heald; Edward J Fudman; Pervin Anklesaria; Philip J Mease
Journal:  J Rheumatol       Date:  2010-03-15       Impact factor: 4.666

6.  Clinical responses to gene therapy in joints of two subjects with rheumatoid arthritis.

Authors:  Peter Wehling; Julio Reinecke; Axel W A Baltzer; Markus Granrath; Klaus P Schulitz; Carl Schultz; Rüdiger Krauspe; Theresa W Whiteside; Elaine Elder; Steven C Ghivizzani; Paul D Robbins; Christopher H Evans
Journal:  Hum Gene Ther       Date:  2009-02       Impact factor: 5.695

Review 7.  Animal models of primary biliary cirrhosis.

Authors:  Jinjun Wang; Guo-Xiang Yang; Koichi Tsuneyama; M Eric Gershwin; William M Ridgway; Patrick S C Leung
Journal:  Semin Liver Dis       Date:  2014-07-24       Impact factor: 6.115

8.  Intraarticular gene transfer of TNFR:Fc suppresses experimental arthritis with reduced systemic distribution of the gene product.

Authors:  James M K Chan; Gilda Villarreal; Wen Wen Jin; Tony Stepan; Haim Burstein; Sharon M Wahl
Journal:  Mol Ther       Date:  2002-12       Impact factor: 11.454

9.  Therapeutic siRNA silencing in inflammatory monocytes in mice.

Authors:  Florian Leuschner; Partha Dutta; Rostic Gorbatov; Tatiana I Novobrantseva; Jessica S Donahoe; Gabriel Courties; Kang Mi Lee; James I Kim; James F Markmann; Brett Marinelli; Peter Panizzi; Won Woo Lee; Yoshiko Iwamoto; Stuart Milstein; Hila Epstein-Barash; William Cantley; Jamie Wong; Virna Cortez-Retamozo; Andita Newton; Kevin Love; Peter Libby; Mikael J Pittet; Filip K Swirski; Victor Koteliansky; Robert Langer; Ralph Weissleder; Daniel G Anderson; Matthias Nahrendorf
Journal:  Nat Biotechnol       Date:  2011-10-09       Impact factor: 54.908

10.  A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease.

Authors:  Zoe Hunter; Derrick P McCarthy; Woon Teck Yap; Christopher T Harp; Daniel R Getts; Lonnie D Shea; Stephen D Miller
Journal:  ACS Nano       Date:  2014-02-27       Impact factor: 15.881

View more
  7 in total

Review 1.  CD24: from a Hematopoietic Differentiation Antigen to a Genetic Risk Factor for Multiple Autoimmune Diseases.

Authors:  Yixin Tan; Ming Zhao; Bo Xiang; Christopher Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

Review 2.  Application and prospect of targeting innate immune sensors in the treatment of autoimmune diseases.

Authors:  Jun Liu; Hui Zhang; Yanhong Su; Baojun Zhang
Journal:  Cell Biosci       Date:  2022-05-26       Impact factor: 9.584

Review 3.  THE JEREMIAH METZGER LECTURE NOVEL THERAPEUTIC STRATEGIES OF ALLERGIC AND IMMUNOLOGIC DISORDERS.

Authors:  Ronald G Crystal; Odelya E Pagovich
Journal:  Trans Am Clin Climatol Assoc       Date:  2018

4.  Multiple Sclerosis Gene Therapy with Recombinant Viral Vectors: Overexpression of IL-4, Leukemia Inhibitory Factor, and IL-10 in Wharton's Jelly Stem Cells Used in EAE Mice Model.

Authors:  Ahmad Hosseini; Hajar Estiri; Haleh Akhavan Niaki; Akram Alizadeh; Baharak Abdolhossein Zadeh; Sayyed Mohammad Hossein Ghaderian; Akbar Farjadfar; Ali Fallah
Journal:  Cell J       Date:  2017-08-19       Impact factor: 2.479

5.  Soluble interleukin 23 receptor gene therapy with adeno-associated vectors for the treatment of multiple sclerosis.

Authors:  Ángel Edo; Juan Francisco Espinosa-Parrilla
Journal:  Neural Regen Res       Date:  2017-10       Impact factor: 5.135

6.  Comparison of the deep immune profiling of B cell subsets between healthy adults and Sjögren's syndrome.

Authors:  Ruiling Feng; Jing Zhao; Feng Sun; Miao Miao; Xiaolin Sun; Jing He; Zhanguo Li
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

Review 7.  Genome Editing Using CRISPR-Cas9 and Autoimmune Diseases: A Comprehensive Review.

Authors:  Min Ho Lee; Jae Il Shin; Jae Won Yang; Keum Hwa Lee; Do Hyeon Cha; Jun Beom Hong; Yeoeun Park; Eugene Choi; Kalthoum Tizaoui; Ai Koyanagi; Louis Jacob; Seoyeon Park; Ji Hong Kim; Lee Smith
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.